Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections
R Nau, F Sörgel, H Eiffert - Clinical microbiology reviews, 2010 - Am Soc Microbiol
The entry of anti-infectives into the central nervous system (CNS) depends on the
compartment studied, molecular size, electric charge, lipophilicity, plasma protein binding …
compartment studied, molecular size, electric charge, lipophilicity, plasma protein binding …
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
AK Marr, WJ Gooderham, REW Hancock - Current opinion in pharmacology, 2006 - Elsevier
Cationic antimicrobial peptides are produced by almost all species of life as a component of
their immediate non-specific defense against infections. The assets of these peptides in …
their immediate non-specific defense against infections. The assets of these peptides in …
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and …
C Liu, A Bayer, SE Cosgrove, RS Daum… - Clinical infectious …, 2011 - academic.oup.com
To clarify whether apoptosis is involved in the injury processes induced by autoantibody
against cardiac β1-adrenoceptor, we investigated the biological and apoptotic effects of …
against cardiac β1-adrenoceptor, we investigated the biological and apoptotic effects of …
Pathogenesis and pathophysiology of pneumococcal meningitis
BB Mook-Kanamori, M Geldhoff… - Clinical microbiology …, 2011 - Am Soc Microbiol
Pneumococcal meningitis continues to be associated with high rates of mortality and long-
term neurological sequelae. The most common route of infection starts by nasopharyngeal …
term neurological sequelae. The most common route of infection starts by nasopharyngeal …
[PDF][PDF] Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus
P Llinares, J Barberán, M Montejo, M Salavert… - Rev Esp …, 2013 - researchgate.net
La creciente tasa de resistencia de Staphylococcus aureus a meticilina (SARM) observada
en la década de los años 90, generó importantes lineas de estudio de nuevos antibióticos …
en la década de los años 90, generó importantes lineas de estudio de nuevos antibióticos …
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
JN Steenbergen, J Alder, GM Thorne… - Journal of antimicrobial …, 2005 - academic.oup.com
Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic
lipopeptide with activity against most Gram-positive pathogens, including vancomycin …
lipopeptide with activity against most Gram-positive pathogens, including vancomycin …
Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin
GL French - Journal of Antimicrobial Chemotherapy, 2006 - academic.oup.com
Over the last decade, methicillin-resistant Staphylococcus aureus (MRSA) strains have
emerged as serious pathogens. These strains are often multiresistant to several antibiotic …
emerged as serious pathogens. These strains are often multiresistant to several antibiotic …
Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact
JA Silverman, LI Mortin, ADG VanPraagh… - Journal of Infectious …, 2005 - academic.oup.com
The lipopeptide daptomycin has been approved for use in skin and skin-structure infections
but has failed to meet statistical noninferiority criteria in a clinical trial for severe community …
but has failed to meet statistical noninferiority criteria in a clinical trial for severe community …
Natural products to drugs: daptomycin and related lipopeptide antibiotics
RH Baltz, V Miao, SK Wrigley - Natural product reports, 2005 - pubs.rsc.org
Covering: 1953 to September 2005Daptomycin (Cubicin®) is a lipopeptide antibiotic
approved in the USA in 2003 for the treatment of skin and skin structure infections caused by …
approved in the USA in 2003 for the treatment of skin and skin structure infections caused by …
Chemoenzymatic approaches for exploring structure–activity relationship studies of bioactive natural products
Spurred by advancements in microbial genetics and enzyme engineering, chemoenzymatic
strategies, which combine enzymatic and synthetic transformations, have increasingly made …
strategies, which combine enzymatic and synthetic transformations, have increasingly made …